News MHRA approves weekly insulin jab Onswik NICE’s recommendation of Onswik in August was subject to MHRA licensing, which has now been granted Shajil Kumar Oct 14, 2026
Obesity & Weight Management Eli Lilly’s retatrutide can help shed up to 60 pounds of body weight Trial data shows that the triple hormone receptor agonist drives 23% body weight reduction and normalises blood sugar in 40% of patients Sreedevi N R Oct 02, 2026
News Sandoz receives Canadian approval for generic semaglutide This will widen its access to a low-cost GLP-1 treatment for adults with type 2 diabetes and support Canada’s healthcare system Sreedevi N R Sep 18, 2026
News Pharmacists backed by Wales’s first national type 2 diabetes toolkits 67% of newly diagnosed individuals experienced feelings of guilt or shame Sreedevi N R Aug 24, 2026
News NICE recommends weekly insulin jab for type 2 diabetes patients Guidance backs Eli Lilly's insulin efsitora alfa (Onswik) for NHS use, offering equal glycemic control to daily glargine and degludec Sreedevi N R Aug 21, 2026
News Type 2 diabetes driving comorbidity burden in developed nations: GlobalData The burden of diagnosed cases of type 2 diabetes in seven major markets, including the UK, is expected to increase at an annual growth rate of 1.2% Shajil Kumar Aug 16, 2026
News Rising cases of type 2 diabetes among women in their 20s White women diagnosed at younger ages had average BMIs around 40, a level that is classified as severe obesity Sreedevi N R Jul 24, 2026
News People with PMOS should have yearly checks: NICE Polyendocrine metabolic ovarian syndrome is often under-diagnosed and inconsistently managed Sreedevi N R Jul 01, 2026
